View Archive: 2012 |
2011 |
2010 |
2009 |
2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998May 15, 2012
Cytokinetics to Hold Annual Meeting of Stockholders
May 9, 2012
Cytokinetics Announces Company Participation and Support of ALS Fundraising Activities in Connection with ALS Awareness Month
April 26, 2012
Cytokinetics, Incorporated Reports First Quarter 2012 Financial Results
April 26, 2012
Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 at the 2012 Experimental Biology Annual Conference
April 25, 2012
Cytokinetics Announces Encouraging Results from Two Phase II Clinical Trials Evaluating CK-2017357 in Patients with Amyotrophic Lateral Sclerosis
April 19, 2012
Cytokinetics to Announce First Quarter Results on April 26, 2012
April 19, 2012
Cytokinetics Announces CK-2017357 Receives Fast Track Designation from the FDA for the Potential Treatment of Amyotrophic Lateral Sclerosis
April 18, 2012
Cytokinetics Announces Clinical Trial Data Relating to CK-2017357 to be Presented at the 64th Annual Meeting of the American Academy of Neurology
March 27, 2012
Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference
March 7, 2012
Cytokinetics Announces Changes to Its Board of Directors
March 6, 2012
Cytokinetics Announces that the European Medicines Agency has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis
March 5, 2012
Cytokinetics Announces Fundamental Research in the Field of Fast Skeletal Muscle Activation Published in the Journal Nature Medicine
February 28, 2012
Cytokinetics to Present at March Healthcare Conferences
February 21, 2012
Cytokinetics Announces Initiation of Phase I Clinical Trial of Oral Formulations of Omecamtiv Mecarbil in Healthy Volunteers
February 6, 2012
Cytokinetics to Present at BIO CEO and Investor Conference
February 2, 2012
Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
January 26, 2012
Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012
